Lataa...
Emerging therapeutic options for myelofibrosis: a Canadian perspective
Myelofibrosis (MF) is a clonal stem cell disorder characterized by cytopenias, splenomegaly, marrow fibrosis, and systemic symptoms due to elevated inflammatory cytokines. MF is associated with decreased survival. The quality of life of patients with MF is similar to other advanced malignancies. All...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484412/ https://ncbi.nlm.nih.gov/pubmed/23119228 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|